Artificial Lung Market Forecast 2026: Where the Industry Is Headed
Uncover key drivers, emerging technologies, and competitive movements shaping the fin field-effect transistor (finfet) 3d transistors market from 2026–2035 with trusted insights from The Business Research Company
What upper market value could the Artificial Lung Market reach by 2030 starting from 2026 levels?
The artificial lung market has experienced significant growth over recent years. It is projected to expand from $2.58 billion in 2025 to reach $2.88 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 11.6%. Historically, this expansion can be attributed to several factors, including a rise in the incidence of acute respiratory failure cases, the early adoption of heart lung machines in cardiothoracic surgery, increased volumes of organ transplant procedures, advancements in membrane artificial lung technology, and the growing utilization of extracorporeal life support systems.
The artificial lung market is anticipated to experience substantial growth over the next few years, with projections indicating a rise to $4.27 billion by 2030, achieving a compound annual growth rate (CAGR) of 10.4%. This expansion during the forecast period is driven by factors such as an escalating demand for critical care life-support devices, an increased focus on developing portable and compact artificial lung systems, greater investment in advanced oxygenation membrane materials, the broadening of applications in emergency and trauma care, and the expanding adoption of minimally invasive extracorporeal support solutions. Noteworthy trends for this period include an uptick in demand for artificial lung systems in instances of severe respiratory failure and critical care management, increased utilization of extracorporeal support devices in complex cardiac and lung transplant surgeries, a rising preference for minimally invasive and temporary lung support alternatives to traditional transplantation, the ongoing development of portable and transport-compatible artificial lung units for emergency care settings, and the wider deployment of membrane-based artificial lung technologies for efficient gas exchange and long-term support.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16591&type=smp
Which Drivers Are Influencing Long-Term Growth In The Artificial Lung Market?
The artificial lung market is projected to expand, driven by the increasing occurrence of respiratory conditions. The rise in these diseases is attributed to various elements, including heightened air pollution, shifts in climate, and evolving lifestyle patterns, which impose a substantial burden on public health. Artificial lungs serve to aid individuals with respiratory ailments by providing necessary oxygenation and removing carbon dioxide from the blood, either assisting or substituting impaired lung function. For example, in June 2024, the Australian Institute of Health and Welfare, an Australia-based health and welfare agency, reported that roughly 8.5 million people in Australia, or 34% of the population, were estimated to have chronic respiratory conditions. This data included an estimated 2.8 million individuals, or 11% of the population, living with asthma, and 638,000 people, or 2.5% of the population, affected by chronic obstructive pulmonary disease (COPD). Consequently, the growing prevalence of respiratory diseases is a primary catalyst for the expansion of the artificial lung market.
Which Segments Are Driving Activity In The Artificial Lung Market?
The artificial lung market covered in this report is segmented –
1) By Product Type: Single Roller Pump Heart Lung Machines, Double Roller Pump Heart Lungs Machines, Bubble Artificial Lung, Membrane Artificial Lung
2) By Application: Cardiac Surgery, Lung Transplant Operation, Acute Respiratory Failure Treatment, Other Applications
3) By End-Users: Hospital, Emergency Center, Other End-users
Subsegments:
1) By Single Roller Pump Heart Lung Machines: Portable Single Roller Pump Heart Lung Machines, Stationary Single Roller Pump Heart Lung Machines
2) By Double Roller Pump Heart Lung Machines: Portable Double Roller Pump Heart Lung Machines, Stationary Double Roller Pump Heart Lung Machines
3) By Bubble Artificial Lung: Disposable Bubble Artificial Lung, Reusable Bubble Artificial Lung
4) By Membrane Artificial Lung: Oxygenator Membrane Artificial Lung, Carbon Dioxide Removal Membrane Artificial Lung
Which Trends Are Expected To Influence The Artificial Lung Market In The Upcoming Years?
Major companies operating in the artificial lung market are concentrating on developing innovative solutions, such as truly portable pneumatic ECMO systems, with the aim of expanding extracorporeal life support beyond the ICU and facilitating rapid transport and field deployment. A pneumatic portable ECMO system operates using oxygen-supply-driven pneumatic pumps and integrated gas management to provide extracorporeal oxygenation and circulatory support without relying on external electric power or heavy motorized components. For instance, in May 2024, Hemovent GmbH, a Germany-based medical device company, announced that MOBYBOX, identified as the world’s first integrated portable pneumatic ECMO system, had completed its initial commercial applications in Europe; MOBYBOX weighs about 2.5 kg, is exclusively driven by the oxygen supply, allowing it to function without a battery or motor, incorporates Bionique Flow Technology for gentler blood handling and improved gas exchange, and has secured Medical Device Regulation certification for its initial markets.
Which Key Players Are Driving Competition In The Artificial Lung Market?
Major companies operating in the artificial lung market are Getinge AB, Medtronic plc, LivaNova PLC, Terumo Corporation, Fresenius Medical Care AG & Co KGaA, ALung Technologies Inc, Xenios AG, Eurosets S.r.l, Nipro Corporation, Braile Biomédica, Hemovent GmbH, MC3 Cardiopulmonary Inc, Abbott Laboratories, Spectrum Medical Ltd, B Braun Melsungen AG, SB-Kawasumi Laboratories Inc, Senko Medical Instrument Mfg Co Ltd, CARMAT, Technowood International Pte Ltd, Elite Lifecare, Cytosorbents Corporation
Access The Complete Report For Deeper Market Insights:
https://www.thebusinessresearchcompany.com/report/artificial-lung-global-market-report
Which Region Is Projected To Lead The Artificial Lung Market During The Forecast Period?
North America was the largest region in the artificial lung market in 2025. The regions covered in the artificial lung market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Artificial Lung Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=16591&type=smp
Browse Through More Reports Similar to the Global Artificial Lung Market 2026, By The Business Research Company
In Vitro Lung Model Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/in-vitro-lung-model-global-market-report
Artificial Intelligence Ai In Respiratory Diseases Global Market Report 2026
Respiratory Devices And Equipment Therapeutic Global Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
